Project Grant R01NS142622
Award Date
6/20/25
Completion Date
3/31/30
Dollars Obligated
$733K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $2,234,905.00 in funding to The University of Iowa to support research aimed at understanding the underlying mechanisms responsible for cognitive fluctuations in Lewy body disorders (LBD). The project will use mouse models to evaluate how the accumulation of...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop and test an advanced magnetic resonance imaging (MRI) technique called velocity-selective arterial spin labeling (VSASL) to serve as a reliable biomarker for detecting early cognitive impairment and disease progression in patients with Lewy body dementia (LBD). The $420,683 award, with a period of performance from September 2024 to July 2029, will fund technical refinements to the...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $655,638 to the University of Denver to develop and test synthetic protein mimetics as potential therapeutics for Lewy body dementia (LBD). The key products and services being delivered under this 2.5-year award include: Optimization and testing of the pharmaceutical properties of oligopyridylamide (OP) synthetic protein mimetics to inhibit alpha-synuclein aggregation and Lewy...
The National Institute on Aging (NIA) awarded a $400,707 Project Grant (CFDA 93.866 - Aging Research) to the University of Florida to map brain lipid architecture in aging, Lewy body dementia (LBD), and T-cell therapy. The 2-year grant, running from September 1, 2024 to August 31, 2026, will utilize novel imaging mass spectrometry to generate a spatial atlas of the lipidome and identify lipid markers of disease progression in LBD. The research aims to assess lipid alterations resulting from an...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports a research project titled "Mechanistic Investigation of Neuropathological Interactions Between COVID-19 and Progression of Lewy Pathology and Dementia". The $506,052 award to Louisiana State University Health Sciences Center-Shreveport will fund a 1-year project...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,510,600 to the University of Wisconsin - Madison to conduct research on mapping synaptic density in prodromal and manifest Lewy body dementia (LBD). The key objectives are to: (1) map differences in synaptic density between healthy controls, individuals with rapid eye movement sleep behavior disorder, early-stage Parkinsonism, and mild cognitive impairment with Lewy bodies; (2) determine...
This three-year, $4.766 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, aims to clarify the neuropathological, molecular, and genetic differences between Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB) through the Aging Research grant program (CFDA 93.866). The J. David Gladstone Institutes will use digital pathology, artificial intelligence, single-nuclei RNA sequencing, and spatial transcriptomics on...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is funding a longitudinal study to evaluate associations between abnormalities in the neuromodulatory system and depression severity, cognition, and motor frailty in older adults with late life depression (LLD). The $818,253 award to the Regents of the University of California, San Francisco (UCSF) will support a 5-year study involving 100 LLD and 50...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, is funding research on the role of microglia/macrophages in Lewy body disorders. The total award amount is $231,826.00, with a project period from September 17, 2024 to August 31, 2026. The key objectives of the research are to: 1) identify the neural cell type most likely...
This $6,226,692 Project Grant awarded by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) program supports research examining the role of neuronal hyperexcitability and proteostasis in the progression of Alzheimer's disease (AD). The study aims to use a mouse model to investigate how modifications in brain activity, specifically in the locus coeruleus (LC) and hippocampus (HPC), can lead to the pathological hallmarks of AD. Key objectives include tracking early...